Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Current evidence on the relationship between two polymorphisms in the NBS1 gene and breast cancer risk: a meta-analysis.

Zhang ZH, Yang LS, Huang F, Hao JH, Su PY, Sun YH.

Asian Pac J Cancer Prev. 2012;13(11):5375-9.

2.

Significant association between Nijmegen breakage syndrome 1 657del5 polymorphism and breast cancer risk.

Zhang G, Zeng Y, Liu Z, Wei W.

Tumour Biol. 2013 Oct;34(5):2753-7. doi: 10.1007/s13277-013-0830-z. Epub 2013 Jun 14.

PMID:
23765759
3.

I171V germline mutation in the NBS1 gene significantly increases risk of breast cancer.

Roznowski K, Januszkiewicz-Lewandowska D, Mosor M, Pernak M, Litwiniuk M, Nowak J.

Breast Cancer Res Treat. 2008 Jul;110(2):343-8. Epub 2007 Sep 26.

PMID:
17899368
4.

Association between the NBS1 Glu185Gln polymorphism and breast cancer risk: a meta-analysis.

Yao F, Fang Y, Chen B, Jin F, Wang S.

Tumour Biol. 2013 Apr;34(2):1255-62. doi: 10.1007/s13277-013-0668-4. Epub 2013 Feb 5.

PMID:
23381647
5.

NBS1 variant I171V and breast cancer risk.

Bogdanova N, Schürmann P, Waltes R, Feshchenko S, Zalutsky IV, Bremer M, Dörk T.

Breast Cancer Res Treat. 2008 Nov;112(1):75-9. Epub 2007 Nov 30.

PMID:
18049891
6.

Heterozygous carriers of the I171V mutation of the NBS1 gene have a significantly increased risk of solid malignant tumours.

Nowak J, Mosor M, Ziółkowska I, Wierzbicka M, Pernak-Schwarz M, Przyborska M, Roznowski K, Pławski A, Słomski R, Januszkiewicz D.

Eur J Cancer. 2008 Mar;44(4):627-30. doi: 10.1016/j.ejca.2008.01.006. Epub 2008 Feb 15.

PMID:
18280732
7.

Functional variants in NBS1 and cancer risk: evidence from a meta-analysis of 60 publications with 111 individual studies.

Gao P, Ma N, Li M, Tian QB, Liu DW.

Mutagenesis. 2013 Nov;28(6):683-97. doi: 10.1093/mutage/get048. Epub 2013 Oct 10.

8.

NBS1 8360G > C polymorphism is associated with breast cancer risk: a meta-analysis.

Wang Z, Cui D, Lu W.

Breast Cancer Res Treat. 2010 Sep;123(2):557-61. doi: 10.1007/s10549-010-0772-8. Epub 2010 Feb 9.

PMID:
20143155
9.

Association of two CASP8 polymorphisms with breast cancer risk: a meta-analysis.

Sergentanis TN, Economopoulos KP.

Breast Cancer Res Treat. 2010 Feb;120(1):229-34. doi: 10.1007/s10549-009-0471-5. Epub 2009 Jul 24.

PMID:
19629679
10.

NBS1 657del5 mutation may contribute only to a limited fraction of breast cancer cases in Russia.

Buslov KG, Iyevleva AG, Chekmariova EV, Suspitsin EN, Togo AV, Kuligina ESh, Sokolenko AP, Matsko DE, Turkevich EA, Lazareva YR, Chagunava OL, Bit-Sava EM, Semiglazov VF, Devilee P, Cornelisse C, Hanson KP, Imyanitov EN.

Int J Cancer. 2005 Apr 20;114(4):585-9.

11.

Role of the Nijmegen breakage syndrome 1 gene in familial and sporadic prostate cancer.

Hebbring SJ, Fredriksson H, White KA, Maier C, Ewing C, McDonnell SK, Jacobsen SJ, Cerhan J, Schaid DJ, Ikonen T, Autio V, Tammela TL, Herkommer K, Paiss T, Vogel W, Gielzak M, Sauvageot J, Schleutker J, Cooney KA, Isaacs W, Thibodeau SN.

Cancer Epidemiol Biomarkers Prev. 2006 May;15(5):935-8.

12.

Association between the NBS1 Glu185Gln polymorphism and lung cancer risk: a systemic review and meta-analysis.

Wang L, Cheng J, Gao J, Wang J, Liu X, Xiong L.

Mol Biol Rep. 2013 Mar;40(3):2711-5. doi: 10.1007/s11033-012-2358-5. Epub 2012 Dec 29. Review.

PMID:
23275190
13.

Germline mutations 657del5 of the NBS1 gene contribute significantly to the incidence of breast cancer in Central Poland.

Steffen J, Nowakowska D, Niwińska A, Czapczak D, Kluska A, Piatkowska M, Wiśniewska A, Paszko Z.

Int J Cancer. 2006 Jul 15;119(2):472-5.

14.

Association of a LSP1 gene rs3817198T>C polymorphism with breast cancer risk: evidence from 33,920 cases and 35,671 controls.

Chen MB, Li C, Shen WX, Guo YJ, Shen W, Lu PH.

Mol Biol Rep. 2011 Oct;38(7):4687-95. doi: 10.1007/s11033-010-0603-3. Epub 2010 Dec 2.

PMID:
21127985
15.

Nijmegen Breakage Syndrome mutations and risk of breast cancer.

Bogdanova N, Feshchenko S, Schürmann P, Waltes R, Wieland B, Hillemanns P, Rogov YI, Dammann O, Bremer M, Karstens JH, Sohn C, Varon R, Dörk T.

Int J Cancer. 2008 Feb 15;122(4):802-6.

16.

GSTT1 and GSTP1 polymorphisms and breast cancer risk: a meta-analysis.

Sergentanis TN, Economopoulos KP.

Breast Cancer Res Treat. 2010 May;121(1):195-202. doi: 10.1007/s10549-009-0520-0. Epub 2009 Sep 17.

PMID:
19760040
17.

Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls.

Qi X, Ma X, Yang X, Fan L, Zhang Y, Zhang F, Chen L, Zhou Y, Jiang J.

Breast Cancer Res Treat. 2010 Sep;123(2):499-506. doi: 10.1007/s10549-010-0773-7. Epub 2010 Feb 5.

PMID:
20135343
18.

Polymorphisms and haplotypes of the NBS1 gene are associated with risk of sporadic breast cancer in non-Hispanic white women <or=55 years.

Lu J, Wei Q, Bondy ML, Li D, Brewster A, Shete S, Yu TK, Sahin A, Meric-Bernstam F, Hunt KK, Singletary SE, Ross MI, Wang LE.

Carcinogenesis. 2006 Nov;27(11):2209-16. Epub 2006 May 19.

19.

Increased cancer risk of heterozygotes with NBS1 germline mutations in Poland.

Steffen J, Varon R, Mosor M, Maneva G, Maurer M, Stumm M, Nowakowska D, Rubach M, Kosakowska E, Ruka W, Nowecki Z, Rutkowski P, Demkow T, Sadowska M, Bidziński M, Gawrychowski K, Sperling K.

Int J Cancer. 2004 Aug 10;111(1):67-71.

20.

Increased risk of larynx cancer in heterozygous carriers of the I171V mutation of the NBS1 gene.

Ziólkowska I, Mosor M, Wierzbicka M, Rydzanicz M, Pernak-Schwarz M, Nowak J.

Cancer Sci. 2007 Nov;98(11):1701-5.

Items per page

Supplemental Content

Write to the Help Desk